Showing results (311-320 of 1,523) with videos related to

Sort By:
Pageof 153
CPT: Pharmacometrics & Systems Pharmacology|February 12, 2024
Application of multistate modeling to clinical data analysisJoachim Grevel, Joshua Veasy, Blesson Chacko
CPT: Pharmacometrics & Systems Pharmacology|March 14, 2024
Physiologically based pharmacokinetic modeling of imatinib and N-desmethyl imatinib for drug-drug interaction predictionsHelena Leonie Hanae Loer, Christina Kovar, Simeon Rüdesheim, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 20, 2024
Physiologically-based pharmacokinetic modeling predicts the drug interaction potential of GLS4 in co-administered with ritonavirZexu Sun, Nan Zhao, Ran Xie, et al.
CPT: Pharmacometrics & Systems Pharmacology|March 26, 2024
Population pharmacokinetic-pharmacodynamic modeling of serum biomarkers as predictors of tumor dynamics following lenvatinib treatment in patients with radioiodine-refractory differentiated thyroid cancer (RR-DTC)Oneeb Majid, Seiichi Hayato, Sree Harsha Sreerama Reddy, et al.
CPT: Pharmacometrics & Systems Pharmacology|March 27, 2024
A population pharmacokinetic model using allometric scaling for baricitinib in patients with juvenile idiopathic arthritisRodney L Decker, C Steven Ernest, David B Radtke, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 3, 2024
Covariate modeling in pharmacometrics: General points for considerationKinjal Sanghavi, Jakob Ribbing, James A Rogers, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 1, 2024
Tofacitinib pharmacokinetics in children and adolescents with juvenile idiopathic arthritisCheng Chang, Camille Vong, Xiaoxing Wang, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 13, 2024
Population pharmacokinetic analysis of zastaprazan (JP-1366), a novel potassium-competitive acid blocker, in patients and healthy volunteersEunsol Yang, Inyoung Hwang, Sang Chun Ji, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 23, 2024
In-host modeling of dengue virus and non-structural protein 1 and the effects of ivermectin in patients with acute dengue feverJunjie Ding, Dumrong Mairiang, Dararat Prayongkul, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 17, 2024
PBPK modeling of recombinant factor IX Fc fusion protein (rFIXFc) and rFIX to characterize the binding to type 4 collagen in the extravascular spaceMichael E Cloesmeijer, Erik Sjögren, Sjoerd F Koopman, et al.
Pageof 153